Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2026-01-13 @ 12:17 PM
Study NCT ID:
NCT03647592
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2018-08-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Sponsor:
Hunan Province Tumor Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-23
First Submit QC Date:
None
Study First Post Date:
2018-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-25
Last Update Post Date:
2023-12-27
Last Update Post Date Type:
ACTUAL